The stock of Edwards Lifesciences Corp (EW) has seen a 0.49% increase in the past week, with a 11.05% gain in the past month, and a 22.87% flourish in the past quarter. The volatility ratio for the week is 1.74%, and the volatility levels for the past 30 days are at 2.18% for EW. The simple moving average for the past 20 days is 2.51% for EW’s stock, with a 19.66% simple moving average for the past 200 days.
Is It Worth Investing in Edwards Lifesciences Corp (NYSE: EW) Right Now?
Edwards Lifesciences Corp (NYSE: EW) has a higher price-to-earnings ratio of 40.95x compared to its average ratio, The 36-month beta value for EW is at 1.05. Analysts have varying views on the stock, with 9 analysts rating it as a “buy,” 7 rating it as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for EW is 591.80M, and currently, shorts hold a 1.77% of that float. The average trading volume for EW on April 02, 2024 was 4.04M shares.
EW) stock’s latest price update
Edwards Lifesciences Corp (NYSE: EW) has seen a decline in its stock price by -1.37 in relation to its previous close of 95.56. However, the company has experienced a 0.49% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-03-25 that Here is how Edwards Lifesciences (EW) and Avinger (AVGR) have performed compared to their sector so far this year.
Analysts’ Opinion of EW
Wells Fargo, on the other hand, stated in their research note that they expect to see EW reach a price target of $94. The rating they have provided for EW stocks is “Overweight” according to the report published on February 02nd, 2024.
Evercore ISI gave a rating of “In-line” to EW, setting the target price at $77 in the report published on January 04th of the current year.
EW Trading at 9.48% from the 50-Day Moving Average
After a stumble in the market that brought EW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -1.95% of loss for the given period.
Volatility was left at 2.18%, however, over the last 30 days, the volatility rate increased by 1.74%, as shares surge +10.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +26.61% upper at present.
During the last 5 trading sessions, EW rose by +0.49%, which changed the moving average for the period of 200-days by +7.84% in comparison to the 20-day moving average, which settled at $92.40. In addition, Edwards Lifesciences Corp saw 23.61% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EW starting from Ullem Scott B., who sale 7,255 shares at the price of $94.89 back on Apr 01 ’24. After this action, Ullem Scott B. now owns 19,074 shares of Edwards Lifesciences Corp, valued at $688,423 using the latest closing price.
BOBO DONALD E JR, the CVP,Strategy/Corp Development of Edwards Lifesciences Corp, sale 14,500 shares at $91.01 during a trade that took place back on Mar 13 ’24, which means that BOBO DONALD E JR is holding 39,503 shares at $1,319,696 based on the most recent closing price.
Stock Fundamentals for EW
Current profitability levels for the company are sitting at:
- 0.26 for the present operating margin
- 0.77 for the gross margin
The net margin for Edwards Lifesciences Corp stands at 0.23. The total capital return value is set at 0.19. Equity return is now at value 22.52, with 15.89 for asset returns.
Based on Edwards Lifesciences Corp (EW), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at 1.29. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -150.4.
Currently, EBITDA for the company is 1.95 billion with net debt to EBITDA at -0.24. When we switch over and look at the enterprise to sales, we see a ratio of 9.36. The receivables turnover for the company is 7.18for trailing twelve months and the total asset turnover is 0.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.38.
Conclusion
In conclusion, Edwards Lifesciences Corp (EW) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
